Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
48
datasets available to search
ShareScore release 0.9.0
Dataset results
48 results for “progressive failure”
Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression
GEO Series GSE135055. Homo sapiens. 60 samples. Type: Expression profiling by high throughput sequencing; Non-coding RNA profiling by high throughput sequencing.
Thrombospondin 1 Aggravates the Progression of Heart Failure with Preserved Ejection Fraction by Inhibiting Mitophagy
GEO Series GSE305470. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Suppression of RBFox2 by Multiple MiRNAs Contributed to Progressive Heart Failure
GEO Series GSE215303. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing; Non-coding RNA profiling by high throughput sequencing.
The Role of Lung and Diaphragm Ultrasonography in Predicting Clinical Progression in Hypoxemic Respiratory Failure
ClinicalTrials.gov study NCT06706830. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs
ClinicalTrials.gov study NCT04519983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Depression and Heart Failure Disease Progression
ClinicalTrials.gov study NCT02131428. IPD Sharing: NO. Countries: 1. Publications: 0.
Heart Failure-USB: Prediction and Progression
ClinicalTrials.gov study NCT04000061. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Elastic Band-Progressive Resistance Training (EB-PRT) for Sarcopenia Among Heart Failure Patients
ClinicalTrials.gov study NCT06161402. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression
ClinicalTrials.gov study NCT00608998. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Can Gdf-15 Level Predict Progression to Multiple Organ Failure in Patients With Septic Shock
ClinicalTrials.gov study NCT06808100. IPD Sharing: NO. Countries: 1. Publications: 0.
Peripheral Drivers of Heart Failure Progression - the Prospective PEDAL-HF Study
ClinicalTrials.gov study NCT06656832. IPD Sharing: YES. Countries: 0. Publications: 0.
Suppression of RBFox2 by Multiple MiRNAs Contributed to Progressive Heart Failure (RNA-Seq)
GEO Series GSE215301. Mus musculus. 4 samples. Type: Expression profiling by high throughput sequencing.
Inhibition of Scarb1 on endothelial cells attenuates pressure overload-induced heart failure progression
GEO Series GSE293318. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure
GEO Series GSE59867. Homo sapiens. 436 samples. Type: Expression profiling by array.
Clinical symptoms of right ventricular failure in experimental chronic pressure load are associated with progressive diastolic dysfunction
GEO Series GSE46863. Rattus norvegicus. 16 samples. Type: Expression profiling by array.
Progression of heart failure induced by tachycardia
GEO Series GSE9794. Canis lupus familiaris. 45 samples. Type: Expression profiling by array.
Regression of Cardiac Hypertrophy and Attenuation of Progression to Heart Failure by Paricalcitol Therapy in Rats
GEO Series GSE24110. Rattus norvegicus. 19 samples. Type: Expression profiling by array.
Dataset related to article "The pattern of failure after Stereotactic Radiation Therapy (SRT) for oligo-metastases: predictive factors for poly-progression "
<p>This record contains raw data related to article "The pattern of failure after Stereotactic Radiation Therapy (SRT) for oligo-metastases: predictive factors for poly-progression"</p><p>Abstract</p><p><strong>Purpose: </strong>Patients with oligo-metastatic disease (OMD) can be safely treated with Stereotactic Radiation Therapy (SRT). Further disease progression is common in these patients. In most cases, patients relapse again with oligo-metastases, however some can experience a poly-progression after a local ablative treatment (LAT). The purpose of this study was to retrospectively identify factors associated with poly-progression in patients receiving SRT for OMD.</p><p><strong>Methods: </strong>Data from a monocentric database were retrospectively analyzed. Patients treated with SRT for OMD and who developed progression after LAT were selected. Patients were categorized as oligo- or poly-progressive according to the number of new/progressing metastases (≤ or > 5). Herein, we analyzed data about patients' characteristics, oligo-metastatic presentation and radiation treatment characteristics to evaluate their relationship with progression type.</p><p><strong>Results: </strong>From 2013 to 2021, data on 700 patients progressing after LAT were analyzed. Among them, 227 patients (32.4%) experienced a poly-progression; the median time to poly-progression was 7.72 months (range 1-79.6). Five variables associated with poly-progression were found to be statistically significant in the univariate analysis: performance status (p < 0.001), site of the primary tumor (p = 0.016), ablative dose (p = 0.002), treated site (p = 0.002), single or double organ (p = 0.03). Of those, all but the number of involved organs retained their significant predictive value on the multivariate analysis.</p><p><strong>Conclusion: </strong>Our study identified four independent factors associated with poly-progression in patients with OMD receiving SRT. Our data may support comprehensive characterization of OMD, better understanding of factors associated with progression.</p>
Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
ClinicalTrials.gov study NCT06327698. IPD Sharing: Not stated. Countries: 0. Publications: 0.
MicroRNAs associated with reverse left ventricular remodeling in humans identify pathways of heart failure progression
GEO Series GSE109051. Homo sapiens. 64 samples. Type: Non-coding RNA profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.